Burden of Anticholinergic Meds in Older Adults Must Be Considered

Share this content:
Burden of Anticholinergic Meds in Older Adults Must Be Considered
Burden of Anticholinergic Meds in Older Adults Must Be Considered

FRIDAY, Dec. 30, 2016 (HealthDay News) -- Anticholinergic medications are frequently prescribed to older adults, but their negative impact should be considered, according to a review published online Dec. 23 in the Journal of Pharmacy Practice and Research.

Noting that anticholinergic medications are often used by older adults to manage a wide range of chronic conditions, Lisa Kouladjian O'Donnell, M.Pharm., Ph.D., from the University of Sydney, and colleagues reviewed the literature published regarding anticholinergic prescribing among older adults.

Anticholinergic medications can have a negative impact in older adults, including central nervous system adverse effects, such as cognitive impairment, confusion, delirium, and falls, as well as peripheral adverse effects such as constipation, dry eyes, and urinary retention. The researchers note that in order to quantify anticholinergic burden, several measures have been developed and validated, including the Anticholinergic Drug Scale, Anticholinergic Risk Scale, and Anticholinergic Cognitive Burden scale. Limited evidence is available for translation of these measures into clinical practice. Interventions, including pharmacist review and integration of anticholinergic burden measures, demonstrate reduction in anticholinergic prescribing. Careful cessation or tapering is involved in deprescribing anticholinergic medication, with consideration of the specific clinical scenario and the pharmacology of the medications.

"Future deprescribing trials may provide further guidance on the implementation of interventions and outcomes of deprescribing anticholinergic medications in clinical practice," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA OKs Drug for Hemophilia A With Factor VIII Inhibitors

FDA OKs Drug for Hemophilia A With Factor ...

Weekly prophylactic treatment associated with substantial decrease in bleeding episodes

Risk of Falls Up With Mild, Moderate Diabetic Retinopathy

Risk of Falls Up With Mild, Moderate Diabetic ...

And perceived barriers to diabetes self-management are associated with severity of diabetic retinopathy

AMD Risk Has Dropped By Birth Cohort Throughout 20th Century

AMD Risk Has Dropped By Birth Cohort Throughout ...

Generational association remains significant after adjustment for age, sex, other confounders

is free, fast, and customized just for you!

Already a member?

Sign In Now »